메뉴 건너뛰기




Volumn 61, Issue 5-6, 2005, Pages 253-258

Modelisation of the association mechanism of a series of huperzine derivatives used for Alzheimer disease with human serum albumin: Effect of the magnesium cation

Author keywords

Affinity chromatography; Alzheimer's disease; Column liquid chromatography; Huperzine; Magnesium cation in human serum albumin

Indexed keywords

HUPERZINE A; MAGNESIUM DERIVATIVE; N BENZOYLHUPERZINE A; N BUTYRYLHUPERZINE A; N HUPERZINE A; N ISOBUTYRYLHUPERZINE A; N ISONICOTINYLHUPERZINE A; N PROPIONYLHUPERZINE A; N VALERYLHUPERZINE A; SERUM ALBUMIN; UNCLASSIFIED DRUG;

EID: 16444378727     PISSN: 00095893     EISSN: None     Source Type: Journal    
DOI: 10.1365/s10337-005-0498-7     Document Type: Article
Times cited : (2)

References (44)
  • 4
    • 0001885399 scopus 로고    scopus 로고
    • Cholinesterase inhibitors: From the calabar bean to Alzheimer therapy
    • Giacobini E ed, Martin Dunitz, Thonex-Geneva
    • Giacobini E (2000) Cholinesterase inhibitors: from the calabar bean to Alzheimer therapy. In: Giacobini E ed, Cholinesterases and Cholinesterase Inhibitors. Martin Dunitz, Thonex-Geneva, pp. 181
    • (2000) Cholinesterases and Cholinesterase Inhibitors , pp. 181
    • Giacobini, E.1
  • 6
    • 0002369017 scopus 로고
    • Cholinomimatic therapy of Alzheimer disease: Does it slow down deterioration?
    • Racagni G, Brunello N, Langer SZ (eds). International Academy Biomedical Drug Research
    • Giacobini E (1994) Cholinomimatic therapy of Alzheimer disease: does it slow down deterioration? In: Racagni G, Brunello N, Langer SZ (eds) Recent Advances in the Treatment of Neurodegenerative Disorders and Congnitive Dysfunction. International Academy Biomedical Drug Research 7(23):51-57
    • (1994) Recent Advances in the Treatment of Neurodegenerative Disorders and Congnitive Dysfunction , vol.7 , Issue.23 , pp. 51-57
    • Giacobini, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.